donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 03347 Tigermed > Main Composition
03347 Tigermed
90.700
-3.100-3.30%
All
YOY
Do not show
Business Unit:CNY

Loading...

Product

Loading...

Region Unit:CNY

Loading...

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

Company Overview More
Hangzhou Tiger Pharmaceutical Technology Co., Ltd. is a Chinese holding company engaged in providing clinical trial services for new drug research and development. The company operates two branches. The Clinical trial Technical Services Division provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies to help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical trial related Services and Laboratory Services Division is engaged in providing analytical services, such as data management and statistical analysis; logistical and executive support services, such as clinical trial site management; administrative assistance, such as patient recruitment; and consulting services. The division, through its subsidiaries, also provides laboratory services for preclinical and clinical development phases. The company operates in both domestic and overseas markets.
CEO: Xiaoping Ye
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...